首页> 外国专利> Connexin enhances chemotherapy-induced apoptosis in human cancer cells inhibiting tumor cell proliferation

Connexin enhances chemotherapy-induced apoptosis in human cancer cells inhibiting tumor cell proliferation

机译:连接蛋白增强化疗诱导的人类癌细胞凋亡,抑制肿瘤细胞增殖

摘要

The present invention provides methods and compositions for the inhibition of proliferation rate of target cells, for example tumor cells. In particular, a nucleic acid encoding a connexin protein, fragment, derivative or analog thereof can be incorporated into a target cell. Expression of the nucleic acid sequence encoding the connexin protein, fragment, derivative or analog thereof, particularly connexin 43 and non-phosphorylated connexin 43, reduces the level of bcl-2 expression in the cells thereby inducing the cells to enter apoptosis. Connexin protein, fragments, derivatives, or analogs thereof can also be administered to the cell population to reduce bcl-2 expression inducing apoptosis in the cell population. It has further been found that the addition of an antagonist of MCP-1 activity can enhance the effects of connexin on tumor cell proliferation. Also, the prognosis of a subject undergoing standard chemotherapy can be assessed by correlating the expression levels of connexin and bcl-2.
机译:本发明提供了用于抑制靶细胞例如肿瘤细胞的增殖速率的方法和组合物。特别地,可以将编码连接蛋白,其片段,衍生物或类似物的核酸掺入靶细胞中。编码连接蛋白,其片段,衍生物或类似物的核酸序列的表达,特别是连接蛋白43和非磷酸化的连接蛋白43的表达,降低了细胞中bcl-2表达的水平,从而诱导细胞进入凋亡状态。连接蛋白,其片段,衍生物或其类似物也可以给予细胞群以减少bcl-2表达诱导细胞群的凋亡。进一步发现,加入MCP-1活性的拮抗剂可以增强连接蛋白对肿瘤细胞增殖的作用。同样,可以通过使连接蛋白和bcl-2的表达水平相关来评估接受标准化学疗法的受试者的预后。

著录项

  • 公开/公告号AU2002252160A1

    专利类型

  • 公开/公告日2002-09-19

    原文格式PDF

  • 申请/专利权人 NORTHWEST BIOTHERAPEUTICS INC.;

    申请/专利号AU20020252160

  • 发明设计人 ALTON L. BOYNTON;RUO-PAN HUANG;

    申请日2002-03-01

  • 分类号A61K48/00;C12Q1/68;A61K38/00;G01N33/53;

  • 国家 AU

  • 入库时间 2022-08-22 00:40:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号